Breaking News Instant updates and real-time market news.

OKE

Oneok

$53.53

-0.32 (-0.59%)

, VLO

Valero

$68.53

0.03 (0.04%)

10:07
08/05/17
08/05
10:07
08/05/17
10:07

Large-cap energy companies in better shape to raise dividends, Barron's says

With oil prices close to $50 a barrel, large-cap energy companies are in better shape to maintain or even raise their dividends than they were a few years ago, when prices collapsed, Lawrence Strauss writes in this week's edition of Barron's. Oneok (OKE), Valero Energy (VLO), Exxon Mobil (XOM), Phillips 66 (PSX), Marathon Petroleum (MPC) and ConocoPhillips (COP) expected to boost their payouts above 2016 levels this year, the publication said. Reference Link

OKE

Oneok

$53.53

-0.32 (-0.59%)

VLO

Valero

$68.53

0.03 (0.04%)

XOM

Exxon Mobil

$80.21

-0.28 (-0.35%)

PSX

Phillips 66

$85.60

-0.05 (-0.06%)

MPC

Marathon Petroleum

$55.79

-0.1 (-0.18%)

COP

ConocoPhillips

$45.56

0.65 (1.45%)

  • 29

    Aug

OKE Oneok
$53.53

-0.32 (-0.59%)

07/06/17
MSCO
07/06/17
INITIATION
Target $54
MSCO
Equal Weight
Oneok initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Tom Abrams resumed coverage on Oneok with an Equal Weight and a $54 price target saying risk/reward appears balanced.
07/05/17
07/05/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Capital One (COF) downgraded to Underperform from Neutral at Wedbush with analyst Henry Coffey saying ROE from operations is much lower than expected, and return on capital measures are sub-optimal. 2. Weyerhaeuser (WY) downgraded to Neutral from Buy at BofA/Merrill with analyst George Staphos saying his thesis has played out and catalysts are limited in the intermediate term. 3. Buffalo Wild Wings (BWLD) downgraded to Equal Weight from Overweight at Stephens with analyst Will Slabaugh saying the proxy fight and management shake-up has created uncertainty regarding the company's future and said a downward revision to guidance is likely due to continued margin pressures, soft topline trends, and lack of near-term catalysts. 4. GlaxoSmithKline (GSK) downgraded to Neutral from Buy at Citi with analyst Andrew Baum saying he believes the market is under-appreciating the slowing of the company's HIV market growth. 5. Oneok (OKE) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Tom Abrams saying risk/reward is balanced. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/05/17
07/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Oracle (ORCL) upgraded to Overweight from Sector Weight at KeyBanc with analyst Monika Garg saying Oracle cloud could double to a $12B run-rate within two years. 2. Chemours (CC) upgraded to Buy from Neutral at Citi with analyst P.J. Juvekar saying the recent stock selloff has created a good entry point. The analyst raised his price target for the shares to $45 from $43. 3. BHP Billiton (BHP) upgraded to Outperform from Market Perform at Bernstein with analyst Paul Gait citing valuation and his belief that the company has "world-class mining portfolio and commodity mix." 4. PPG (PPG) upgraded to Buy from Hold at Argus with analyst Bill Selesky saying he believes that the company "will benefit from improving economic conditions in Europe." 5. Oneok (OKE) upgraded on lower risk, overblown concerns at BMO Capital with analyst Danilo Juvane saying the large increase in the percentage of the company's EBITDA coming from fee-based and take-or-pay assets in the past few years has significantly lowered the company's risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/05/17
MSCO
07/05/17
DOWNGRADE
MSCO
Equal Weight
Oneok downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Tom Abrams resumed coverage on Oneok with an Equal Weight from Overweight with a $54 price target saying risk/reward is balanced.
VLO Valero
$68.53

0.03 (0.04%)

05/30/17
05/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ambarella (AMBA) downgraded to Sector Weight from Overweight at Pacific Crest with analyst Brad Erickson citing concern the company's largest customer DJI may have dual-sourced. After speaking with DJI customer service, Erickson believes Ambarella may not be the video processing provider for Spark, the $499 drone launched last week by DJI. 2. Buffalo Wild Wings (BWLD) downgraded to Underperform from Neutral at Wedbush with analyst Nick Setyan saying the upcoming proxy vote is irrelevant as neither management's strategy nor Marcato Capital's plan offer a viable solution to the company's ongoing deterioration in fundamentals. 3. Valero (VLO) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Benny Wong citing refining headwinds and high exposure to RIN prices. 4. AutoZone (AZO) and O'Reilly Automotive (ORLY) were downgraded to Neutral from Outperform at Wedbush. 5. Whiting Petroleum (WLL) was downgraded to Sell from Neutral at Goldman Sachs, while Cimarex Energy (XEC) and Hess Corp. (HES) were downgraded to Neutral from Buy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/30/17
STPT
06/30/17
INITIATION
Target $84
STPT
Reduce
Valero initiated with an Accumulate at Standpoint Research
Standpoint Research analyst Ronnie Moas started Valero with an Accumulate rating and $84 price target.
06/22/17
JEFF
06/22/17
UPGRADE
Target $80
JEFF
Buy
Valero upgraded to Buy from Hold at Jefferies
Jefferies analyst Christopher Sighinolfi upgraded Valero to Buy from Hold, stating that he expects U.S. crude exports to climb "meaningfully" through the end of the decade. As the largest PADD 3 refiner, he sees Valero's Gulf Coast margin capture improving through 2018, he tells investors. Sighinolfi raised his price target on Valero shares to $80 from $65.
06/02/17
LEHM
06/02/17
INITIATION
Target $118
LEHM
Overweight
Tesoro reinstated with an Overweight at Barclays
Barclays analyst Paul Cheng reinstated coverage of Tesoro (TSO) with an Overweight rating and $118 price target. Tesoro replaces Valero (VLO) as his Top Pick in the Refiners sector following its acquisition of Western Refining.
XOM Exxon Mobil
$80.21

-0.28 (-0.35%)

07/11/17
LEHM
07/11/17
UPGRADE
Target $94
LEHM
Overweight
Exxon Mobil upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Paul Cheng upgraded Exxon Mobil to Overweight citing the recent underperformance of the shares as well as the company's "leading near-term position" in the current commodity price environment. The analyst keeps a $94 price target for the shares.
07/17/17
WOLF
07/17/17
DOWNGRADE
WOLF
Underperform
Exxon Mobil downgraded to Underperform from Peer Perform at Wolfe Research
07/11/17
07/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. KeyCorp (KEY) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Klock saying he sees valuation expansion as the market further appreciates the company's leading return on assets and stable earnings. 2. Exxon Mobil (XOM) and Imperial Oil (IMO) were upgraded to Overweight from Equal Weight at Barclays. 3. Westar Energy (WR) was upgraded to Outperform from In Line at Evercore ISI and to Overweight from Neutral at JPMorgan. 4. STMicroelectronics (STM) upgraded to Overweight from Neutral at JPMorgan with analyst Sandeep Deshpande citing the stock's underperformance over the past three months. 5. J.M. Smucker (SJM) upgraded to Long-Term Buy on valuation at Hilliard Lyons with analyst Jeffrey Thomison citing the recent decline in shares and maintained a $140 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/17
BERN
07/11/17
NO CHANGE
BERN
Oil price forecast cut at Bernstein
Bernstein analysts lowered their 2017 and 2018 oil price forecasts to $50 per barrel for both years. As reasons for the drop, the firm cited higher U.s. shale efficiency, their belief that elevated production levels will last longer than previously expected, and their belief that OPEC cuts will be insufficient to counter increased production by Libya, Iran and Nigeria. Publicly traded companies in the oil space include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT).
PSX Phillips 66
$85.60

-0.05 (-0.06%)

09/30/16
09/30/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded on potential NXP Semiconductors acquisition at Mizuho with the firm's analyst saying he believes a Qualcomm acquisition of NXP Semiconductors (NXPI) makes significant strategic and financial sense. 2. Skechers (SKX) upgraded to Positive from Neutral at Susquehanna. 3. Sprouts Farmers Markets (SFM) upgraded to Buy from Hold at Jefferies with analyst Christopher Mandeville saying the risk/reward is now favorable following the recent pullback in the shares. 4. Phillips 66 (PSX) upgraded to Neutral from Sell at Goldman with analyst Neil Mehta citing higher multiple assumptions for midstream and chemicals segments, reduced capex spending and higher free cash flow estimates, and more achievable consensus expectations. 5. NetApp (NTAP) upgraded to Buy from Sell at Summit Redstone with analyst Srini Nandury citing optimism that the company can grow its product revenue from current levels driven by AFA sales and increasing adoption of clustered ONTAP. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/25/17
05/25/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chipotle (CMG) upgraded to Buy from Hold at Argus with analyst John Staszak saying he expects Chipotle to post above-peer-average growth over the next several quarters due to its new marketing initiatives, differentiated menu and unit expansion plans. Further, Staszak sees fast-casual restaurants like Chipotle growing faster than the overall restaurant industry. He points out that Chipotle posted a strong recovery in both comp sales and earnings in the first quarter. 2. Alliance Data (ADS) upgraded to Neutral from Sell at Compass Point. 3. PVH Corp. (PVH) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss citing the company's first quarter results. The beat and raise story in retail is a rarity, Boss tells investors in a research note. He sees increased visibility to a "sustainable double-digit bottom-line profile" over the longer term. 4. Marathon Petroleum (MPC) and Phillips 66 (PSX) were assumed with an Overweight from Neutral at Piper Jaffray. 5. Alexion (ALXN) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Matthew Harrison saying he believes investors are overlooking ALXN1210 upside potential, are too negative on Solris and believes new Chief Executive Officer Ludwig Hantson is making progress on refocusing efforts and right sizing the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/25/17
PIPR
05/25/17
UPGRADE
Target $88
PIPR
Overweight
Phillips 66 assumed with an Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Guy Baber upgraded Phillips 66 (PSX) to Overweight after assuming coverage of the name. The analyst keeps an $88 price target for the shares. He notes Tesoro (TSO) remains his top pick in the space.
03/24/17
FBCO
03/24/17
NO CHANGE
Target $83
FBCO
Neutral
Phillips 66 price target lowered to $83 from $90 at Credit Suisse
Credit Suisse analyst Edward Westlake lowered his price target for Phillips 66 to $83 from $90 on valuation. The analyst notes that Phillips 66 has been one of the more fully valued refiners for quite some time, but is getting closer to the time when the cash flow power of the company will expand to support its enterprise value. He reiterates a Neutral rating on the shares.
MPC Marathon Petroleum
$55.79

-0.1 (-0.18%)

05/25/17
PIPR
05/25/17
UPGRADE
Target $62
PIPR
Overweight
Marathon Petroleum assumed with an Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Guy Baber upgraded Marathon Petroleum to Overweight after assuming coverage of the name. The analyst raised his price target for the shares to $62 from $48. The analyst notes Tesoro (TSO) remains his top pick in the space.
05/16/17
GSCO
05/16/17
DOWNGRADE
Target $73
GSCO
Neutral
Valero downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Neil Mehta downgraded Valero (VLO) to Neutral citing a more balanced risk/reward following the stock's outperformance. Further, the analyst thinks the upcoming OPEC meeting could drive further compression of the light-heavy differential. He lowered his 6-month target for the shares to $73 from $74. Mehta this morning also upgraded Delek US (DK) to Buy, kept a Buy rating on Marathon Petroleum (MRC) and a Sell rating on HollyFrontier (HFC).
07/20/17
JEFF
07/20/17
NO CHANGE
Target $65
JEFF
Buy
Marathon Petroleum removed as Franchise Pick at Jefferies
Jefferies analyst Corey Goldman removed Marathon Petroleum from his firm's Franchise Pick list saying he sees "only modest upside" if a Speedway separation were to occur. As such, he does not expect Marathon to execute a tax-free separation of Speedway. The analyst keeps a Buy rating on the shares with a $65 price target.
COP ConocoPhillips
$45.56

0.65 (1.45%)

07/17/17
WOLF
07/17/17
DOWNGRADE
WOLF
Peer Perform
ConocoPhillips downgraded to Peer Perform from Outperform at Wolfe Research
07/28/17
BOFA
07/28/17
UPGRADE
Target $58
BOFA
Buy
ConocoPhillips upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Doug Leggate upgraded ConocoPhillips to Buy and raised its price target to $58 from $51 saying portfolio repositioning has lowered capital intensity and will drive free cash flow improvement. The company lowered its breakeven to $45/bbl from $50/bbl in November of 2016 providing capacity for renewed growth capital or buybacks.
07/28/17
07/28/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ConocoPhillips (COP) upgraded to Buy from Neutral at BofA/Merrill with analyst Doug Leggate saying portfolio repositioning has lowered capital intensity and will drive free cash flow improvement. 2. Boeing (BA) upgraded to Neutral from Underperform at Buckingham. 3. J.M. Smucker (SJM) upgraded to Buy from Hold at Jefferies with analyst Akshay Jagdale saying the recent share weakness is overdone. 4. Domino's Pizza (DPZ) upgraded to Buy from Neutral at Longbow. 5. Spirit Airlines (SAVE) upgraded to Buy from Neutral at Citi with analyst Kevin Crissey saying the risks are more than priced in at current share levels. He cut his price target for the shares to $52 from $65. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

15:26
01/20/18
01/20
15:26
01/20/18
15:26
Hot Stocks
Opdivo, Yervoy combo demonstrates activity in patients with dMMR, MSI-H mCRC »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

EXEL

Exelixis

$28.00

0.14 (0.50%)

, RHHBY

Roche

$30.69

0.18 (0.59%)

15:22
01/20/18
01/20
15:22
01/20/18
15:22
Hot Stocks
Exelixis presents updated results from Phase 1b clinical trial in CRC »

Exelixis (EXEL) announced…

EXEL

Exelixis

$28.00

0.14 (0.50%)

RHHBY

Roche

$30.69

0.18 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

  • 08

    Feb

  • 15

    Feb

  • 23

    Feb

ARRY

Array BioPharma

$13.14

0.26 (2.02%)

15:17
01/20/18
01/20
15:17
01/20/18
15:17
Hot Stocks
Array BioPharma updates results from BEACON Phase 3 trial »

Array BioPharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

  • 30

    Jun

SO

Southern Company

$44.44

-0.46 (-1.02%)

15:13
01/20/18
01/20
15:13
01/20/18
15:13
Hot Stocks
Southern Company accelerates restoration efforts in Puerto Rico »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$29.43

0.19 (0.65%)

15:10
01/20/18
01/20
15:10
01/20/18
15:10
Hot Stocks
Teck Resources announces Elkview incident »

Teck Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

TWTR

Twitter

$23.66

-0.38 (-1.58%)

14:03
01/20/18
01/20
14:03
01/20/18
14:03
Hot Stocks
Twitter begins notifying users exposed to Russian propaganda during elections »

Twitter, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

, SPX

S&P 500

13:58
01/20/18
01/20
13:58
01/20/18
13:58
Periodicals
Government shuts down on anniversary of Trump presidency, Reuters reports »

President's Trump…

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

13:48
01/20/18
01/20
13:48
01/20/18
13:48
Periodicals
NY Times stock jumps after Facebook's announcement, Recode reports »

Facebook (FB) CEO Mark…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

WMT

Walmart

$104.59

0.29 (0.28%)

13:36
01/20/18
01/20
13:36
01/20/18
13:36
Periodicals
Still time to shop Walmart shares as company makes changes, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, NFLX

Netflix

$220.46

0.13 (0.06%)

08:59
01/20/18
01/20
08:59
01/20/18
08:59
Periodicals
Netflix among likely candidates for an Apple purchase, Barron's says »

Especially for tech…

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 01

    Feb

BA

Boeing

$337.73

-2.43 (-0.71%)

08:50
01/20/18
01/20
08:50
01/20/18
08:50
Periodicals
Boeing not a sell just yet, Barron's says »

Boeing stock has come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, EADSY

Airbus

$28.43

0.755 (2.73%)

08:24
01/20/18
01/20
08:24
01/20/18
08:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$178.46

-0.8 (-0.45%)

EADSY

Airbus

$28.43

0.755 (2.73%)

BA

Boeing

$337.73

-2.43 (-0.71%)

VZ

Verizon

$51.91

0.36 (0.70%)

NYT

New York Times

$21.90

1.7 (8.42%)

TWX

Time Warner

$93.36

0.39 (0.42%)

DIS

Disney

$110.59

0.17 (0.15%)

TIME

Time Inc.

$18.55

0.05 (0.27%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

BAC

Bank of America

$31.72

0.24 (0.76%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BK

BNY Mellon

$56.61

1.26 (2.28%)

WLKP

Westlake Chemical Partners

$24.45

-0.1 (-0.41%)

MON

Monsanto

$120.66

1.8 (1.51%)

DLTR

Dollar Tree

$114.73

1.83 (1.62%)

CE

Celanese

$112.96

1.93 (1.74%)

LYB

LyondellBasell

$119.92

3.03 (2.59%)

TSE

Trinseo

$79.45

2.2 (2.85%)

EYE

National Vision

$43.13

1.12 (2.67%)

ETFC

E-Trade

$54.28

0.63 (1.17%)

LPLA

LPL Financial

$59.03

0.53 (0.91%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

SCHW

Charles Schwab

$55.48

0.15 (0.27%)

ADS

Alliance Data

$261.82

5.88 (2.30%)

FISV

Fiserv

$138.11

0.17 (0.12%)

FLT

FleetCor

$206.65

3.4 (1.67%)

HAWK

Blackhawk

$45.25

0.1 (0.22%)

MTZ

MasTec

$53.30

1.25 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 02

    Feb

  • 06

    Feb

  • 07

    Feb

  • 15

    Feb

  • 16

    Feb

  • 21

    Feb

  • 08

    Mar

  • 18

    Mar

CME

CME Group

$154.28

2.07 (1.36%)

, GS

Goldman Sachs

$256.12

5.15 (2.05%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Bar Association to hold annual meeting »

Derivatives & Futures…

CME

CME Group

$154.28

2.07 (1.36%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BP

BP

$42.40

-0.5 (-1.17%)

C

Citi

$78.30

0.91 (1.18%)

BAC

Bank of America

$31.72

0.24 (0.76%)

CS

Credit Suisse

$19.06

0.13 (0.69%)

CRL

Charles River

$107.89

1.22 (1.14%)

MS

Morgan Stanley

$57.46

1.62 (2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

AMGN

Amgen

$189.28

1.69 (0.90%)

, BAYRY

Bayer

$32.05

0.235 (0.74%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2018 ASCO…

AMGN

Amgen

$189.28

1.69 (0.90%)

BAYRY

Bayer

$32.05

0.235 (0.74%)

BLRX

BioLineRx

$1.09

-0.02 (-1.80%)

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

CELG

Celgene

$102.65

0.93 (0.91%)

DNA

Bought by RHHBY

ESALY

Eisai

$56.88

0.115 (0.20%)

EXEL

Exelixis

$28.00

0.14 (0.50%)

HALO

Halozyme

$17.98

0.13 (0.73%)

INCY

Incyte

$93.16

1.24 (1.35%)

IPSEY

Ipsen

$34.65

0.75 (2.21%)

LXRX

Lexicon

$10.44

0.2 (1.95%)

MGNX

MacroGenics

$19.19

0.3 (1.59%)

MRK

Merck

$61.28

0.15 (0.25%)

NVS

Novartis

$86.94

0.53 (0.61%)

SNY

Sanofi

$44.60

0.09 (0.20%)

ONCY

Oncolytics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 02

    Feb

  • 03

    Feb

  • 05

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 02

    Mar

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

  • 23

    Oct

WLFC

Willis Lease

$26.66

0.05 (0.19%)

18:59
01/19/18
01/19
18:59
01/19/18
18:59
Hot Stocks
Willis Lease announces $1,000 bonus for employees »

Willis Lease announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary at MUFG »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

GRPN

Groupon

$5.57

0.46 (9.00%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Hot Stocks
Groupon announces Chief Product Officer Jay Sullivan resigns »

On January 17, Jay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41
Hot Stocks
Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial »

Celgene announced primary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

VALU

Value Line

$19.60

0.3 (1.55%)

17:40
01/19/18
01/19
17:40
01/19/18
17:40
Hot Stocks
Value Line reaffirms $3M stock repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALU

Value Line

$19.60

0.3 (1.55%)

17:39
01/19/18
01/19
17:39
01/19/18
17:39
Hot Stocks
Value Line declares special dividend of 20c per share »

Payable on March 9 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEAL

Zealand Pharma

$15.05

-0.78 (-4.93%)

17:34
01/19/18
01/19
17:34
01/19/18
17:34
Hot Stocks
Zealand Pharma: FDA approves IND for Phase 3 trials of dasiglucagon in CHI »

The U.S. FDA has approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.